Be part of the knowledge.™

Drug Eluting Stents

Media Formats

ReachMD Healthcare Image

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details

Presenters

Overview
Though previously believed to be the best solution for reducing the risk of restenosis, studies now show that Drug Eluting Stents, or DES, may actually be more prone to late, sudden occlusion of the coronary artery.

Roxanna Mehran, MD

Roxanna Mehran, MD

Larry Kaskel, MD

Larry Kaskel, MD

Recommended

Details

Presenters

Overview
Though previously believed to be the best solution for reducing the risk of restenosis, studies now show that Drug Eluting Stents, or DES, may actually be more prone to late, sudden occlusion of the coronary artery.

Roxanna Mehran, MD

Roxanna Mehran, MD

Larry Kaskel, MD

Larry Kaskel, MD

Program Chapters

Segment Chapters

Playlist:

Recommended

Beyond Longevity: Discussing TAVR Durability for Women & Patients With Small Annuli

CME/CE Broadcast Replay

Love Story: Lipid Education for Women’s Heart Health

HF Management for Patients with Comorbid Conditions

Level Up Your Skills: Tailoring Management of HF

Clinical Conundrums in ARIA: Communicating ARIA Risk with Patients Considering Anti-Aβ Therapy

Navigating Myasthenia Gravis in Adolescents and Young Adults

Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids

Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF